Replimune Group, Inc. (REPL)

3.72 -0.35 (-8.60%) USD  |  NASDAQ  |  May 11, 16:00
3.75 +0.03 (+0.81%) After-Hours: 16:28
More

Replimune Group Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade